Product Information
LUBIPROSTONE 8 MCG CAPSULE is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.6039 per EA under NDC 31722040360. Its NADAC has been published 40 times since Sep 24, 2025.
Strength
.008 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722040360
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LUBIPROSTONEApproval Type
Generic (ANDA)
FDA Application
ANDA218640On Market Since
5/27/2025
Pharmacological Classes
Price Statistics
The NADAC for LUBIPROSTONE 8 MCG CAPSULE has been published 40 times since Sep 24, 2025, and over the history we have for it it has declined 20.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6039 per EA |
|---|---|
| All-time high | $0.7578 (Oct 15, 2025) |
| All-time low | $0.6039 (Jun 17, 2026) |
| 52-week high | $0.7578 |
| 52-week low | $0.6039 |
| Median price | $0.6990 |
| Average price | $0.7072 |
| Largest weekly change | -15.7% (Jun 17, 2026) |
| Weeks tracked | 40 |
| Tracking since | Sep 24, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LUBIPROSTONE 8 MCG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LUBIPROSTONE 8 MCG CAPSULE, manufactured by Camber Pharmaceuticals Inc., is $0.6039 per EA (NDC 31722040360), effective Jun 24, 2026.
How has the price of LUBIPROSTONE 8 MCG CAPSULE changed over time?
Over the history we have for it, the NADAC for LUBIPROSTONE 8 MCG CAPSULE has declined 20.3%. It has been tracked across 40 weekly CMS publications since Sep 24, 2025.
What are the highest and lowest recorded NADAC prices for LUBIPROSTONE 8 MCG CAPSULE?
Since Sep 24, 2025, the NADAC for LUBIPROSTONE 8 MCG CAPSULE has ranged from a low of $0.6039 (Jun 17, 2026) to a high of $0.7578 (Oct 15, 2025), with a median of $0.6990 per EA.
Are there cheaper alternatives to LUBIPROSTONE 8 MCG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as LUBIPROSTONE 8 MCG CAPSULE, but none are currently priced below it.
Who manufactures LUBIPROSTONE 8 MCG CAPSULE?
LUBIPROSTONE 8 MCG CAPSULE (NDC 31722040360) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification